作为新型癌症治疗方法的异环衍生物的最新发展:从2020年到2024年
Sucheta Singh1, Hrithik Dey2, Meenakshi Kaira2
1Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India.
Mini reviews in medicinal chemistry
|January 9, 2026
概括
异环化合物对于开发新的抗癌药物至关重要. 它们独特的结构和与生物点相互作用的能力为癌症治疗提供了更好的疗效和更少的副作用.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 在瘤学瘤学.
背景情况:
- 癌症仍然是全球主要的死亡原因,需要不断改进治疗策略.
- 异环组是药物发现中的关键支架,因为它们的结构多功能性和生物标相互作用.
- 这些循环化合物中的异原子调节了参与瘤进展,亡和扩散的关键细胞通路.
研究的目的:
- 综合分析异环基团在抗癌药物开发中的作用.
- 审查这个快速发展的领域的最新进展和未来前景.
- 为设计更有效,更有针对性的癌症疗法做出贡献.
主要方法:
- 对抗癌症药物发现中的异环化合物现有文献的综述.
- 对结构修改和混合化策略进行分析,以加强活动.
- 探索计算机建模和先进的药物输送系统.
主要成果:
- 在异环结构中,芳香环和非芳香环的杂化产生了具有增强抗癌活性,选择性和减少不良影响的衍生物.
- 异环衍生物在调节瘤进展,亡和扩散方面表现出显著的潜力.
- 计算机建模和先进的交付系统的整合提高了治疗潜力.
结论:
- 在现代抗癌药物开发中,异环基分子是不可或缺的.
- 对分子框架,计算设计和传递系统的持续研究将推动未来的治疗进步.
- 本综述总结了关键发现和新兴趋势,以指导下一代癌症疗法的发展.
更多相关视频
09:13Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis
Published on: January 5, 2024
1.9K
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
14.4K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
Cancer Vaccines
946
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
946
